Article Menu

Academic Editors

S. Louise Cosby

Pedro Plans-Rubió
Subscribe SciFeed
Recommended Articles
Related Info Link
- Google Scholar
More by Authors Links

/ajax/scifeed/subscribe

Article Views

Citations -

Altmetric Share Help Cite Discuss in SciProfiles

Need Help?

Support

Find support for a specific problem in the support section of our website.

Get Support

Feedback

Please let us know what you think of our products and services.

Give Feedback

Information

Visit our dedicated information section to learn more about MDPI.

Get Information

Open AccessReview

Article Versions Notes

Vaccines 2025, 13(8), 791; https://doi.org/10.3390/vaccines13080791

Action	Date	Notes	Link
article pdf uploaded.	25 July 2025 17:06 CEST	Version of Record	https://www.mdpi.com/2076-393X/13/8/791/pdf

Cite

Export citation file: BibTeX | EndNote | RIS

MDPI and ACS Style

Boccalini, S.; Gironi, V.; Buscemi, P.; Bonanni, P.; Muzii, B.; Parisi, S.; Borchiellini, M.; Bechini, A. The Number Needed to Immunize (NNI) to Assess the Benefit of a Prophylaxis Intervention with Monoclonal Antibodies Against RSV. Vaccines 2025, 13, 791. https://doi.org/10.3390/vaccines13080791

AMA Style

Boccalini S, Gironi V, Buscemi P, Bonanni P, Muzii B, Parisi S, Borchiellini M, Bechini A. The Number Needed to Immunize (NNI) to Assess the Benefit of a Prophylaxis Intervention with Monoclonal Antibodies Against RSV. Vaccines. 2025; 13(8):791. https://doi.org/10.3390/vaccines13080791

Chicago/Turabian Style

Boccalini, Sara, Veronica Gironi, Primo Buscemi, Paolo Bonanni, Barbara Muzii, Salvatore Parisi, Marta Borchiellini, and Angela Bechini. 2025. "The Number Needed to Immunize (NNI) to Assess the Benefit of a Prophylaxis Intervention with Monoclonal Antibodies Against RSV" Vaccines 13, no. 8: 791. https://doi.org/10.3390/vaccines13080791

APA Style

Boccalini, S., Gironi, V., Buscemi, P., Bonanni, P., Muzii, B., Parisi, S., Borchiellini, M., & Bechini, A. (2025). The Number Needed to Immunize (NNI) to Assess the Benefit of a Prophylaxis Intervention with Monoclonal Antibodies Against RSV. Vaccines, 13(8), 791. https://doi.org/10.3390/vaccines13080791

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI